MOURITZEN, Mette T. et al. Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study. Acta Oncologica, [S. l.], v. 61, n. 4, p. 409–416, 2022. DOI: 10.1080/0284186X.2021.2023213. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/21472. Acesso em: 13 may. 2026.